Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 2 Prostatic Neoplasms 2 Sarcoma, Ewing 1 Prostate Adenocarcinoma 1 Pancreatic Neoplasms 1 Endometrial Neoplasms 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 4 Vincristine 3 Temozolomide 3 Magnetic Resonance Spectroscopy 3 Ifosfamide 3 Etoposide 3 Doxorubicin 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 liposomal doxorubicin 2 ivosidenib 2 cabozantinib 2 X-Rays 2 Topotecan 2 Specimen Handling 2 Radiation 2 Phantoms, Imaging 2 Nuclear Medicine Department, Hospital 2 Irinotecan 2 Eflornithine 2 Congresses as Topic 2 trifluridine tipiracil drug combination 1 tazemetostat 1 talazoparib 1 palbociclib 1 olaparib 1 larotrectinib 1 irinotecan sucrosofate 1 ganitumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × Radiation Dose Hypofractionation × 30 days × Clear all

NCT07188532 2026-06-04

BEAR

Mayo Clinic

Phase NA Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡